Jay Therapeutics

Gent ·KBO/BCE: BE 0771.305.101

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	-36.1%	48.3%	better than 5% of 78 sector peers
Net result	€-90k	€17k	better than 18% of 77 sector peers
Equity	€-60k	€70k	better than 5% of 78 sector peers
Gross operating margin	€-12k	€49k	better than 15% of 74 sector peers
Total assets	€166k	€234k	better than 40% of 78 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€166k
Fixed assets	21/28	€20k
Intangible fixed assets	21	€20k
Current assets	29/58	€146k
Amounts receivable within one year	40/41	€2k
Cash & bank	54/58	€23k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€166k
Equity	10/15	€-60k
Contributions / capital	10/11	€2.60M
Accumulated profits (losses)	14	€-2.66M
Amounts payable	17/49	€226k
Amounts payable within one year	42/48	€226k
Trade debts payable within one year	44	€22k
Income statement
Gross operating margin	9900	€-12k
Operating result	9901	€-78k
Financial charges	65	€12k
Result before taxes	9903	€-90k
Net result for the period	9904	€-90k
Result to be appropriated	9905	€-90k

Summary